HP
Hound Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $43.9M | Sell |
181,936
-19,847
| -10% | -$4.79M | 5.93% | 7 |
|
|
2025
Q1 | $49.1M | Buy |
201,783
+142,925
| +243% | +$34.8M | 9.75% | 5 |
|
|
2024
Q4 | $19.3M | Sell |
58,858
-9,502
| -14% | -$3.12M | 7.42% | 3 |
|
|
2024
Q3 | $22.9M | Sell |
68,360
-96,510
| -59% | -$32.3M | 5.72% | 6 |
|
|
2024
Q2 | $45M | Sell |
164,870
-99,667
| -38% | -$27.2M | 9.03% | 4 |
|
|
2024
Q1 | $91.5M | Buy |
264,537
+2,873
| +1% | +$994K | 27.27% | 1 |
|
|
2023
Q4 | $84.5M | Buy |
261,664
+47,682
| +22% | +$15.4M | 26.33% | 1 |
|
|
2023
Q3 | $76.7M | Sell |
213,982
-2,564
| -1% | -$919K | 17% | 2 |
|
|
2023
Q2 | $82.1M | Buy |
216,546
+96,970
| +81% | +$36.8M | 18.63% | 1 |
|
|
2023
Q1 | $57.3M | Buy |
119,576
+31,222
| +35% | +$15M | 14.42% | 1 |
|
|
2022
Q4 | $37.2M | Buy |
88,354
+34,947
| +65% | +$14.7M | 10.99% | 5 |
|
|
2022
Q3 | $22.3M | Sell |
53,407
-10,014
| -16% | -$4.18M | 4.23% | 8 |
|
|
2022
Q2 | $31.4M | Buy |
+63,421
| New | +$31.4M | 2.55% | 12 |
|
|
2021
Q3 | – | Sell |
-72,264
| Closed | -$46.6M | – | 208 |
|
|
2021
Q2 | $46.6M | Sell |
72,264
-5,593
| -7% | -$3.6M | 2.25% | 16 |
|
|
2021
Q1 | $44.5M | Buy |
77,857
+4,285
| +6% | +$2.45M | 2.1% | 17 |
|
|
2020
Q4 | $42.9M | Sell |
73,572
-13,522
| -16% | -$7.88M | 2.72% | 17 |
|
|
2020
Q3 | $44.9M | Sell |
87,094
-558
| -0.6% | -$288K | 3.04% | 15 |
|
|
2020
Q2 | $39.6M | Sell |
87,652
-22,300
| -20% | -$10.1M | 3.6% | 13 |
|
|
2020
Q1 | $38.5M | Buy |
+109,952
| New | +$38.5M | 3.6% | 12 |
|